ABUS

#2558
Arbutus Biopharma Corporation Common Stock
4.48 USD
+2.99%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
4.48
4.48
年范围
2.94
5.10
日变化
+2.99%
每月变动
+4.19%
6个月变化
-0.44%
年变化
+41.32%
前一天收盘价
4.35
开盘价
4.48
买价
卖价
最低价
4.48
High
4.48
交易量
75
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 875.74 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-28.29
市销率
65.44

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

新闻